AstraZeneca | Investor Day Presentation Deck | 49 slides · page 22 of 49
Includes clinical trial design diagram for Part A and Part B.
Conference presentation · problem_statement · diagnose_problem · overcrowded density
Slide locked Sign in to view
Slide schematic 8/8
callout 1/1 diagram 1/1 image 2/2 list 1/1 source-note 1/1 title 2/2
Components 8
primary process illustration photo bullet source-note action-title headline
Tools 2
Problem-Agitate-Solve (PAS) slide · 60%
Inflammation causing painful, itchy skin rashes across body; Progressive muscular weakness may lead to respiratory failure and death
Problem Statement Canvas slide · 70%Significant unmet need, limited competition with c.189k diagnosed patients in Top 8 countries
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1